25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

CRVO (Cervomed) Stock Analysis
Buy, Hold or Sell?

Let's analyze Cervomed together

I guess you are interested in CervoMed Inc.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Cervomed’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Cervomed’s Price Targets

I'm going to help you getting a better view of CervoMed Inc.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about CervoMed Inc.

I send you an email if I find something interesting about CervoMed Inc..

1. Quick Overview

1.1. Quick analysis of Cervomed (30 sec.)










1.2. What can you expect buying and holding a share of Cervomed? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$3.98
Expected worth in 1 year
$7.35
How sure are you?
25.0%

+ What do you gain per year?

Total Gains per Share
$3.37
Return On Investment
44.2%

For what price can you sell your share?

Current Price per Share
$7.62
Expected price per share
$2.51 - $11.79
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Cervomed (5 min.)




Live pricePrice per Share (EOD)
$7.62
Intrinsic Value Per Share
$-16.66 - $-6.79
Total Value Per Share
$-12.68 - $-2.81

2.2. Growth of Cervomed (5 min.)




Is Cervomed growing?

Current yearPrevious yearGrowGrow %
How rich?$34.6m$9.1m$33.2m78.4%

How much money is Cervomed making?

Current yearPrevious yearGrowGrow %
Making money-$4.6m-$1.2m-$3.4m-74.1%
Net Profit Margin-17.6%-15.3%--

How much money comes from the company's main activities?

2.3. Financial Health of Cervomed (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Cervomed?

Welcome investor! Cervomed's management wants to use your money to grow the business. In return you get a share of Cervomed.

First you should know what it really means to hold a share of Cervomed. And how you can make/lose money.

Speculation

The Price per Share of Cervomed is $7.62. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Cervomed.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Cervomed, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $3.98. Based on the TTM, the Book Value Change Per Share is $0.84 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.31 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Cervomed.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.56-7.4%-0.54-7.0%-0.14-1.8%-0.34-4.5%-0.42-5.5%-0.37-4.9%
Usd Book Value Change Per Share-0.52-6.9%0.8411.0%-0.31-4.1%0.040.5%0.101.3%0.000.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.52-6.9%0.8411.0%-0.31-4.1%0.040.5%0.101.3%0.000.0%
Usd Price Per Share9.15-10.80-9.72-8.61-5.43-3.63-
Price to Earnings Ratio-4.07--6.90--6.49--5.96--3.74--2.30-
Price-to-Total Gains Ratio-17.43--11.64--38.10--21.01--12.92--7.78-
Price to Book Ratio2.30-2.15-13.31-5.86-3.58--2.56-
Price-to-Total Gains Ratio-17.43--11.64--38.10--21.01--12.92--7.78-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share7.62
Number of shares131
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.840.10
Usd Total Gains Per Share0.840.10
Gains per Quarter (131 shares)110.2512.59
Gains per Year (131 shares)441.0250.38
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1044143105040
20882872010190
30132313130151140
40176417540202190
50220521950252240
60264626360302290
70308730770353340
80352835180403390
90396939590453440
100441044000504490

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%1.011.00.08.3%1.019.00.05.0%4.036.00.010.0%7.075.00.08.5%
Book Value Change Per Share1.03.00.025.0%1.011.00.08.3%3.017.00.015.0%10.030.00.025.0%27.054.01.032.9%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.082.00.0%
Total Gains per Share1.03.00.025.0%1.011.00.08.3%3.017.00.015.0%10.030.00.025.0%27.054.01.032.9%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of CervoMed Inc. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.5250.842-162%-0.314-40%0.038-1465%0.096-646%-0.002-100%
Book Value Per Share--3.9804.868-18%1.049+279%2.807+42%3.373+18%2.508+59%
Current Ratio--20.73415.400+35%5.565+273%10.423+99%11.929+74%8.963+131%
Debt To Asset Ratio--0.1020.080+28%0.223-54%0.134-24%0.111-8%0.243-58%
Debt To Equity Ratio--0.1140.087+31%0.303-62%0.166-32%0.134-15%0.966-88%
Dividend Per Share----0%-0%-0%-0%-0%
Enterprise Value--110931401.000131919698.710-16%92212391.200+20%97215005.091+14%72804001.360+52%44029347.598+152%
Eps---0.562-0.536-5%-0.139-75%-0.342-39%-0.416-26%-0.374-33%
Ev To Ebitda Ratio---5.230-7.743+48%-10.066+92%-7.429+42%-5.253+0%-3.263-38%
Free Cash Flow Per Share---0.447-0.639+43%-0.112-75%-0.396-12%-0.406-9%-0.353-21%
Free Cash Flow To Equity Per Share---0.4470.694-164%0.208-315%0.155-389%0.218-305%0.097-562%
Gross Profit Margin--1.0001.0000%1.207-17%1.192-16%1.115-10%1.057-5%
Intrinsic Value_10Y_max---6.793----------
Intrinsic Value_10Y_min---16.658----------
Intrinsic Value_1Y_max---1.308----------
Intrinsic Value_1Y_min---1.609----------
Intrinsic Value_3Y_max---3.452----------
Intrinsic Value_3Y_min---4.915----------
Intrinsic Value_5Y_max---5.019----------
Intrinsic Value_5Y_min---8.284----------
Market Cap66314726.400-20%79629888.00094011507.460-15%84612195.200-6%74943090.508+6%47282648.910+68%31583013.348+152%
Net Profit Margin----0.1760%-0.1530%-0.3520%-0.2110%-0.1060%
Operating Margin----0.2280%-1.3210%-0.8530%-0.5120%-0.2560%
Operating Ratio---0.478-100%2.593-100%1.385-100%0.831-100%0.415-100%
Pb Ratio1.915-20%2.2992.146+7%13.310-83%5.861-61%3.583-36%-2.564+212%
Pe Ratio-3.388+17%-4.068-6.896+70%-6.488+60%-5.964+47%-3.742-8%-2.303-43%
Price Per Share7.620-20%9.15010.803-15%9.723-6%8.611+6%5.433+68%3.629+152%
Price To Free Cash Flow Ratio-4.257+17%-5.112-6.647+30%-10.294+101%-6.716+31%-4.193-18%-2.999-41%
Price To Total Gains Ratio-14.518+17%-17.433-11.635-33%-38.104+119%-21.010+21%-12.917-26%-7.777-55%
Quick Ratio--32.24125.489+26%5.055+538%15.544+107%15.271+111%10.397+210%
Return On Assets---0.127-0.106-17%-0.1270%-0.132+4%-0.132+4%-0.162+27%
Return On Equity---0.141-0.116-18%-0.179+27%-0.159+12%-0.152+8%0.300-147%
Total Gains Per Share---0.5250.842-162%-0.314-40%0.038-1465%0.096-646%-0.002-100%
Usd Book Value--34634487.00042362806.000-18%9129248.250+279%24432173.417+42%29353829.900+18%21826519.250+59%
Usd Book Value Change Per Share---0.5250.842-162%-0.314-40%0.038-1465%0.096-646%-0.002-100%
Usd Book Value Per Share--3.9804.868-18%1.049+279%2.807+42%3.373+18%2.508+59%
Usd Dividend Per Share----0%-0%-0%-0%-0%
Usd Enterprise Value--110931401.000131919698.710-16%92212391.200+20%97215005.091+14%72804001.360+52%44029347.598+152%
Usd Eps---0.562-0.536-5%-0.139-75%-0.342-39%-0.416-26%-0.374-33%
Usd Free Cash Flow---3894359.000-5560080.750+43%-976350.250-75%-3446095.417-12%-3531653.100-9%-3072146.950-21%
Usd Free Cash Flow Per Share---0.447-0.639+43%-0.112-75%-0.396-12%-0.406-9%-0.353-21%
Usd Free Cash Flow To Equity Per Share---0.4470.694-164%0.208-315%0.155-389%0.218-305%0.097-562%
Usd Market Cap66314726.400-20%79629888.00094011507.460-15%84612195.200-6%74943090.508+6%47282648.910+68%31583013.348+152%
Usd Price Per Share7.620-20%9.15010.803-15%9.723-6%8.611+6%5.433+68%3.629+152%
Usd Profit---4894034.000-4667598.500-5%-1209868.250-75%-3222253.167-34%-3945794.850-19%-3422730.625-30%
Usd Revenue---822242.750-100%1591077.500-100%921762.417-100%553057.450-100%276528.725-100%
Usd Total Gains Per Share---0.5250.842-162%-0.314-40%0.038-1465%0.096-646%-0.002-100%
 EOD+3 -5MRQTTM+8 -26YOY+15 -203Y+18 -175Y+19 -1610Y+16 -19

3.3 Fundamental Score

Let's check the fundamental score of CervoMed Inc. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-3.388
Price to Book Ratio (EOD)Between0-11.915
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than132.241
Current Ratio (MRQ)Greater than120.734
Debt to Asset Ratio (MRQ)Less than10.102
Debt to Equity Ratio (MRQ)Less than10.114
Return on Equity (MRQ)Greater than0.15-0.141
Return on Assets (MRQ)Greater than0.05-0.127
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of CervoMed Inc. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5042.852
Ma 20Greater thanMa 508.212
Ma 50Greater thanMa 1008.999
Ma 100Greater thanMa 2006.358
OpenGreater thanClose7.630
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About CervoMed Inc.

CervoMed Inc., a a clinical-stage biotechnology company, engages in the development and commercialization of treatments for age-related neurologic disorders. The company is developing neflamapimod, an orally administered small molecule brain penetrant that inhibits p38 mitogen-activated protein kinase alpha. Neflamapimod has the potential to treat synaptic dysfunction, the reversible aspect of the underlying neurodegenerative processes that cause disease in DLB and certain other major neurological disorders. It is being evaluated in a Phase 2b study in patients with DLB. The company develops EIP200 for central nervous system which is in preclinical trials. CervoMed Inc. was founded in 2010 and is headquartered in Boston, Massachusetts.

Fundamental data was last updated by Penke on 2025-05-21 01:58:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is very efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Cervomed earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareΒ Cervomed to theΒ Biotechnology industry mean.
  • A Net Profit Margin of 0.0%Β means thatΒ $0.00 for each $1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of CervoMed Inc.:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-17.6%+17.6%
TTM-17.6%YOY-15.3%-2.3%
TTM-17.6%5Y-21.1%+3.5%
5Y-21.1%10Y-10.6%-10.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--94.3%+94.3%
TTM-17.6%-144.8%+127.2%
YOY-15.3%-195.4%+180.1%
3Y-35.2%-254.0%+218.8%
5Y-21.1%-346.4%+325.3%
10Y-10.6%-473.5%+462.9%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Cervomed is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Cervomed to theΒ Biotechnology industry mean.
  • -12.7% Return on Assets means thatΒ Cervomed generatedΒ $-0.13 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of CervoMed Inc.:

  • The MRQ is -12.7%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -10.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-12.7%TTM-10.6%-2.1%
TTM-10.6%YOY-12.7%+2.1%
TTM-10.6%5Y-13.2%+2.6%
5Y-13.2%10Y-16.2%+3.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-12.7%-11.3%-1.4%
TTM-10.6%-11.3%+0.7%
YOY-12.7%-11.0%-1.7%
3Y-13.2%-11.7%-1.5%
5Y-13.2%-11.9%-1.3%
10Y-16.2%-13.8%-2.4%
4.3.1.3. Return on Equity

Shows how efficient Cervomed is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Cervomed to theΒ Biotechnology industry mean.
  • -14.1% Return on Equity means Cervomed generated $-0.14Β for eachΒ $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of CervoMed Inc.:

  • The MRQ is -14.1%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -11.6%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-14.1%TTM-11.6%-2.6%
TTM-11.6%YOY-17.9%+6.3%
TTM-11.6%5Y-15.2%+3.7%
5Y-15.2%10Y30.0%-45.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-14.1%-13.0%-1.1%
TTM-11.6%-14.2%+2.6%
YOY-17.9%-14.3%-3.6%
3Y-15.9%-16.9%+1.0%
5Y-15.2%-17.2%+2.0%
10Y30.0%-20.2%+50.2%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of CervoMed Inc..

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Cervomed is operatingΒ .

  • Measures how much profit Cervomed makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Cervomed to theΒ Biotechnology industry mean.
  • An Operating Margin of 0.0%Β means the company generated $0.00 Β for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of CervoMed Inc.:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-22.8%+22.8%
TTM-22.8%YOY-132.1%+109.4%
TTM-22.8%5Y-51.2%+28.4%
5Y-51.2%10Y-25.6%-25.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--204.6%+204.6%
TTM-22.8%-249.0%+226.2%
YOY-132.1%-209.2%+77.1%
3Y-85.3%-219.3%+134.0%
5Y-51.2%-345.5%+294.3%
10Y-25.6%-448.5%+422.9%
4.3.2.2. Operating Ratio

Measures how efficient Cervomed is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of CervoMed Inc.:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM0.478-0.478
TTM0.478YOY2.593-2.116
TTM0.4785Y0.831-0.353
5Y0.83110Y0.415+0.415
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.110-2.110
TTM0.4782.679-2.201
YOY2.5933.063-0.470
3Y1.3853.620-2.235
5Y0.8314.745-3.914
10Y0.4156.379-5.964
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of CervoMed Inc..

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Cervomed is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Biotechnology industry mean).
  • A Current Ratio of 20.73Β means the company has $20.73 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of CervoMed Inc.:

  • The MRQ is 20.734. The company is very able to pay all its short-term debts. +2
  • The TTM is 15.400. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ20.734TTM15.400+5.334
TTM15.400YOY5.565+9.835
TTM15.4005Y11.929+3.472
5Y11.92910Y8.963+2.966
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ20.7343.582+17.152
TTM15.4003.745+11.655
YOY5.5654.149+1.416
3Y10.4234.663+5.760
5Y11.9295.767+6.162
10Y8.9636.141+2.822
4.4.3.2. Quick Ratio

Measures if Cervomed is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Cervomed to theΒ Biotechnology industry mean.
  • A Quick Ratio of 32.24Β means the company can pay off $32.24 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of CervoMed Inc.:

  • The MRQ is 32.241. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 25.489. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ32.241TTM25.489+6.752
TTM25.489YOY5.055+20.434
TTM25.4895Y15.271+10.218
5Y15.27110Y10.397+4.874
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ32.2412.914+29.327
TTM25.4893.198+22.291
YOY5.0553.790+1.265
3Y15.5444.308+11.236
5Y15.2715.703+9.568
10Y10.3976.505+3.892
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of CervoMed Inc..

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of CervomedΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Cervomed to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.10Β means that Cervomed assets areΒ financed with 10.2% credit (debt) and the remaining percentage (100% - 10.2%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of CervoMed Inc.:

  • The MRQ is 0.102. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.080. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.102TTM0.080+0.022
TTM0.080YOY0.223-0.143
TTM0.0805Y0.111-0.031
5Y0.11110Y0.243-0.132
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1020.336-0.234
TTM0.0800.356-0.276
YOY0.2230.335-0.112
3Y0.1340.339-0.205
5Y0.1110.349-0.238
10Y0.2430.383-0.140
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Cervomed is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Cervomed to theΒ Biotechnology industry mean.
  • A Debt to Equity ratio of 11.4% means that company has $0.11 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of CervoMed Inc.:

  • The MRQ is 0.114. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.087. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.114TTM0.087+0.027
TTM0.087YOY0.303-0.216
TTM0.0875Y0.134-0.047
5Y0.13410Y0.966-0.832
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1140.391-0.277
TTM0.0870.435-0.348
YOY0.3030.416-0.113
3Y0.1660.461-0.295
5Y0.1340.461-0.327
10Y0.9660.510+0.456
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every $1 in earnings Cervomed generates.

  • Above 15 is considered overpriced butΒ always compareΒ Cervomed to theΒ Biotechnology industry mean.
  • A PE ratio of -4.07 means the investor is paying $-4.07Β for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of CervoMed Inc.:

  • The EOD is -3.388. Based on the earnings, the company is expensive. -2
  • The MRQ is -4.068. Based on the earnings, the company is expensive. -2
  • The TTM is -6.896. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3.388MRQ-4.068+0.680
MRQ-4.068TTM-6.896+2.829
TTM-6.896YOY-6.488-0.408
TTM-6.8965Y-3.742-3.155
5Y-3.74210Y-2.303-1.438
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-3.388-2.001-1.387
MRQ-4.068-2.027-2.041
TTM-6.896-2.527-4.369
YOY-6.488-3.674-2.814
3Y-5.964-3.702-2.262
5Y-3.742-6.083+2.341
10Y-2.303-6.657+4.354
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of CervoMed Inc.:

  • The EOD is -4.257. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -5.112. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -6.647. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-4.257MRQ-5.112+0.855
MRQ-5.112TTM-6.647+1.535
TTM-6.647YOY-10.294+3.647
TTM-6.6475Y-4.193-2.453
5Y-4.19310Y-2.999-1.195
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-4.257-2.830-1.427
MRQ-5.112-2.674-2.438
TTM-6.647-3.579-3.068
YOY-10.294-4.430-5.864
3Y-6.716-5.235-1.481
5Y-4.193-8.286+4.093
10Y-2.999-9.133+6.134
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Cervomed is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Biotechnology industry mean).
  • A PB ratio of 2.30 means the investor is paying $2.30Β for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of CervoMed Inc.:

  • The EOD is 1.915. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.299. Based on the equity, the company is underpriced. +1
  • The TTM is 2.146. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.915MRQ2.299-0.384
MRQ2.299TTM2.146+0.153
TTM2.146YOY13.310-11.165
TTM2.1465Y3.583-1.437
5Y3.58310Y-2.564+6.147
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.9151.962-0.047
MRQ2.2991.884+0.415
TTM2.1462.192-0.046
YOY13.3102.490+10.820
3Y5.8612.614+3.247
5Y3.5833.682-0.099
10Y-2.5644.311-6.875
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of CervoMed Inc..

3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2024-03-312024-06-302024-09-302024-12-312025-03-31
Other Current Liabilities  1,354-2881,0661,0682,1331942,327-4,188-1,861



5.2. Latest Balance Sheet

Balance Sheet of 2025-03-31. Currency in USD. All numbers in thousands.

Summary
Total Assets38,577
Total Liabilities3,943
Total Stockholder Equity34,634
 As reported
Total Liabilities 3,943
Total Stockholder Equity+ 34,634
Total Assets = 38,577

Assets

Total Assets38,577
Total Current Assets38,577
Long-term Assets0
Total Current Assets
Cash And Cash Equivalents 10,502
Short-term Investments 24,743
Other Current Assets 3,333
Total Current Assets  (as reported)38,577
Total Current Assets  (calculated)38,577
+/-0
Long-term Assets
Long-term Assets  (as reported)0
Long-term Assets  (calculated)0
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities1,861
Long-term Liabilities2,082
Total Stockholder Equity34,634
Total Current Liabilities
Accounts payable 1,861
Other Current Liabilities -1,861
Total Current Liabilities  (as reported)1,861
Total Current Liabilities  (calculated)0
+/- 1,861
Long-term Liabilities
Long-term Liabilities  (as reported)2,082
Long-term Liabilities  (calculated)0
+/- 2,082
Total Stockholder Equity
Common Stock9
Retained Earnings -75,626
Accumulated Other Comprehensive Income 21
Other Stockholders Equity 110,230
Total Stockholder Equity (as reported)34,634
Total Stockholder Equity (calculated)34,634
+/-0
Other
Capital Stock9
Cash and Short Term Investments 35,245
Common Stock Shares Outstanding 8,703
Liabilities and Stockholders Equity 38,577
Net Debt -10,502
Net Invested Capital 34,634
Net Working Capital 34,634



5.3. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302000-09-302000-06-302000-03-311999-12-311999-09-301999-06-301999-03-311998-12-311998-09-30
> Total Assets 
18,100
18,500
20,500
22,800
25,900
22,181
22,323
19,354
12,751
0
0
0
0
0
6,703
6,968
6,721
6,694
5,362
5,350
5,563
5,322
4,283
5,495
6,035
6,177
5,576
5,449
12,467
9,081
3,674
3,575
3,709
3,944
2,446
2,188
197
3,235
18,344
26,448
54,529
50,547
42,779
39,622
36,654
23,378
2,277
22,911
19,924
19,047
17,484
36,344
33,906
28,327
26,146
33,367
29,944
23,595
18,202
15,988
18,929
16,197
24,111
21,057
35,993
31,917
27,730
56,213
52,711
40,881
37,839
33,574
29,184
26,323
22,635
18,405
15,695
12,038
9,973
7,997
53,191
48,884
43,082
38,577
38,57743,08248,88453,1917,9979,97312,03815,69518,40522,63526,32329,18433,57437,83940,88152,71156,21327,73031,91735,99321,05724,11116,19718,92915,98818,20223,59529,94433,36726,14628,32733,90636,34417,48419,04719,92422,9112,27723,37836,65439,62242,77950,54754,52926,44818,3443,2351972,1882,4463,9443,7093,5753,6749,08112,4675,4495,5766,1776,0355,4954,2835,3225,5635,3505,3626,6946,7216,9686,7030000012,75119,35422,32322,18125,90022,80020,50018,50018,100
   > Total Current Assets 
17,400
17,200
19,200
21,100
23,800
20,065
20,300
17,430
10,910
0
0
0
0
0
188
468
235
221
219
219
443
213
4
515
898
801
613
540
6,973
3,525
186
97
253
734
462
212
166
3,210
2,998
2,678
29,438
26,009
24,171
21,001
17,830
15,630
2,043
6,251
3,244
3,287
1,604
20,632
17,701
12,241
9,666
17,090
13,707
11,570
8,914
6,384
9,409
6,718
14,650
11,716
26,709
22,677
18,776
47,314
43,860
40,715
37,824
33,574
29,184
26,323
22,635
18,405
15,695
11,843
9,965
7,718
47,328
48,810
43,082
38,577
38,57743,08248,81047,3287,7189,96511,84315,69518,40522,63526,32329,18433,57437,82440,71543,86047,31418,77622,67726,70911,71614,6506,7189,4096,3848,91411,57013,70717,0909,66612,24117,70120,6321,6043,2873,2446,2512,04315,63017,83021,00124,17126,00929,4382,6782,9983,210166212462734253971863,5256,97354061380189851542134432192192212354681880000010,91017,43020,30020,06523,80021,10019,20017,20017,400
       Cash And Cash Equivalents 
600
0
200
0
1,000
34
1,072
164
151
0
0
0
0
0
0
0
16
3
1
0
200
0
0
465
58
13
0
0
5,865
2,129
98
13
43
157
312
111
79
256
255
222
27,140
23,788
21,884
19,210
16,473
14,581
1,997
5,866
3,006
3,021
1,553
12,212
7,413
1,216
8,896
16,199
12,935
11,018
7,991
5,334
8,373
6,140
14,177
10,828
25,562
21,910
18,516
46,635
43,308
40,335
37,314
9,872
5,966
6,587
10,114
14,646
15,000
10,425
7,793
6,369
10,009
7,744
8,999
10,502
10,5028,9997,74410,0096,3697,79310,42515,00014,64610,1146,5875,9669,87237,31440,33543,30846,63518,51621,91025,56210,82814,1776,1408,3735,3347,99111,01812,93516,1998,8961,2167,41312,2121,5533,0213,0065,8661,99714,58116,47319,21021,88423,78827,140222255256791113121574313982,1295,865001358465002000131600000001511641,072341,00002000600
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
22,680
22,575
19,271
12,409
2,992
0
0
0
0
35,083
38,913
29,923
24,743
24,74329,92338,91335,08300002,99212,40919,27122,57522,68000000000000000000000000000000000000000000000000000000000000000000000000
       Net Receivables 
4,400
4,700
6,500
6,700
5,600
2,228
3,670
2,402
2,013
0
0
0
0
0
0
280
10
10
10
10
10
10
0
0
0
0
0
0
54
59
0
0
72
539
72
72
59
53
2
0
0
0
0
0
0
0
0
0
0
0
0
8,281
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
915
0
0
264
2,254
0
02,25426400915000000000000000000000000008,281000000000000253597272539720059540000001010101010102800000002,0132,4023,6702,2285,6006,7006,5004,7004,400
       Inventory 
11,100
11,800
11,700
13,600
16,300
17,452
15,281
14,607
8,659
0
0
0
0
0
9
9
9
9
9
9
9
9
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000000000000000000000000000000000099999999000008,65914,60715,28117,45216,30013,60011,70011,80011,100
       Other Current Assets 
1,300
700
800
800
900
351
277
257
87
0
0
0
0
0
178
178
199
199
199
199
223
193
4
50
840
788
613
540
1,054
1,337
88
84
138
38
78
29
28
2,901
2,741
2,456
2,299
2,220
2,287
1,791
1,357
1,049
46
385
238
265
51
139
10,288
11,025
770
891
773
551
923
1,050
1,037
579
472
888
1,147
767
261
679
552
380
510
1,021
644
465
64
768
695
1,419
1,186
1,349
2,236
1,889
2,111
3,333
3,3332,1111,8892,2361,3491,1861,419695768644656441,0215103805526792617671,1478884725791,0371,05092355177389177011,02510,28813951265238385461,0491,3571,7912,2872,2202,2992,4562,7412,9012829783813884881,3371,05454061378884050419322319919919919917817800000872572773519008008007001,300
   > Long-term Assets 
700
1,300
1,300
1,700
2,100
2,117
2,023
1,925
1,841
0
0
0
0
0
6,515
6,501
6,486
6,472
5,143
5,131
5,120
5,109
4,279
4,980
5,137
5,376
4,962
4,909
5,494
5,556
3,488
3,478
3,456
3,210
1,985
1,976
32
24
15,346
23,770
25,091
24,538
18,608
18,621
18,824
7,748
233
16,660
16,680
15,760
15,881
15,712
16,205
16,087
16,479
16,277
16,236
12,025
9,288
9,604
9,520
9,479
9,461
9,341
9,284
9,240
8,953
8,899
8,851
165
16
0
0
0
0
0
0
194
8
280
5,862
74
0
0
00745,8622808194000000161658,8518,8998,9539,2409,2849,3419,4619,4799,5209,6049,28812,02516,23616,27716,47916,08716,20515,71215,88115,76016,68016,6602337,74818,82418,62118,60824,53825,09123,77015,34624321,9761,9853,2103,4563,4783,4885,5565,4944,9094,9625,3765,1374,9804,2795,1095,1205,1315,1436,4726,4866,5016,515000001,8411,9252,0232,1172,1001,7001,3001,300700
       Property Plant Equipment 
600
1,100
1,200
1,600
2,000
2,014
1,921
1,823
1,710
0
0
0
0
0
13
10
7
4
2
2
2
2
2
1
3
10
10
8
88
126
78
68
96
49
49
40
32
24
11
82
56
54
102
115
69
63
52
104
91
86
80
80
480
480
461
433
406
379
350
645
589
549
499
449
393
349
298
245
197
150
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000001501972452983493934494995495896453503794064334614804808080869110452636911510254568211243240494996687812688810103122222471013000001,7101,8231,9212,0142,0001,6001,2001,100600
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,073
2,073
2,073
2,073
1,073
1,073
1,073
1,073
1,073
1,073
1,073
1,073
1,073
1,073
3,073
3,108
3,009
0
3,009
3,009
1,936
1,936
0
0
7,643
13,963
11,242
11,525
12,056
12,056
12,056
985
0
7,105
7,105
6,929
6,929
6,929
6,929
6,929
6,929
6,929
6,929
2,743
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000002,7436,9296,9296,9296,9296,9296,9296,9296,9297,1057,105098512,05612,05612,05611,52511,24213,9637,643001,9361,9363,0093,00903,0093,1083,0731,0731,0731,0731,0731,0731,0731,0731,0731,0731,0732,0732,0732,0732,07300000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,806
0
0
0
0005,80600000000000000000000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
100
100
100
100
100
85
85
85
84
0
0
0
0
0
4,429
4,418
4,406
4,395
4,067
4,056
4,045
4,033
2,951
2,940
2,928
2,917
2,256
2,244
2,233
2,222
351
0
351
153
0
0
0
0
7,692
9,725
13,793
12,959
6,450
6,450
6,450
6,450
6,450
9,317
9,317
8,639
8,639
8,639
8,639
8,639
8,639
8,639
8,639
8,639
8,639
8,639
8,639
8,639
8,639
8,639
8,639
8,639
8,639
8,639
8,639
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000008,6398,6398,6398,6398,6398,6398,6398,6398,6398,6398,6398,6398,6398,6398,6398,6398,6398,6398,6398,6399,3179,3176,4506,4506,4506,4506,45012,95913,7939,7257,692000015335103512,2222,2332,2442,2562,9172,9282,9402,9514,0334,0454,0564,0674,3954,4064,4184,4290000084858585100100100100100
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
12,400
13,000
14,500
17,200
17,600
19,411
18,544
16,114
13,238
0
143
148
191
204
7,609
7,428
7,479
7,634
4,923
5,076
5,083
5,277
3,789
4,105
4,388
4,590
5,555
6,172
3,813
3,963
19,675
5,769
8,777
9,981
20,853
21,925
8,767
9,571
11,879
14,233
9,232
7,748
4,613
4,367
4,842
4,309
2,318
6,332
5,892
7,561
8,300
55,462
32,739
21,971
4,916
3,646
2,644
2,687
2,590
3,033
2,752
2,678
3,976
3,156
3,116
3,193
2,915
2,566
2,544
2,749
2,928
2,956
2,515
2,271
2,417
2,126
1,465
2,464
2,596
2,661
3,214
3,246
3,879
3,943
3,9433,8793,2463,2142,6612,5962,4641,4652,1262,4172,2712,5152,9562,9282,7492,5442,5662,9153,1933,1163,1563,9762,6782,7523,0332,5902,6872,6443,6464,91621,97132,73955,4628,3007,5615,8926,3322,3184,3094,8424,3674,6137,7489,23214,23311,8799,5718,76721,92520,8539,9818,7775,76919,6753,9633,8136,1725,5554,5904,3884,1053,7895,2775,0835,0764,9237,6347,4797,4287,609204191148143013,23816,11418,54419,41117,60017,20014,50013,00012,400
   > Total Current Liabilities 
10,300
4,700
5,300
6,000
6,000
16,763
16,821
13,531
10,731
0
143
148
191
204
6,609
6,428
6,479
6,634
4,298
4,076
4,458
4,652
3,164
3,480
3,763
3,965
4,930
5,547
3,188
3,338
19,675
5,769
8,777
9,981
20,853
21,925
8,767
9,571
8,878
10,695
4,131
2,977
2,339
2,093
2,568
2,035
1,471
2,208
1,757
3,681
4,438
51,599
29,459
18,691
2,691
1,423
688
946
804
1,193
1,043
1,218
1,721
1,287
1,782
2,687
2,436
2,113
2,101
2,749
2,928
2,956
2,515
2,271
2,417
2,126
1,465
2,464
2,596
2,661
3,214
3,246
3,879
1,861
1,8613,8793,2463,2142,6612,5962,4641,4652,1262,4172,2712,5152,9562,9282,7492,1012,1132,4362,6871,7821,2871,7211,2181,0431,1938049466881,4232,69118,69129,45951,5994,4383,6811,7572,2081,4712,0352,5682,0932,3392,9774,13110,6958,8789,5718,76721,92520,8539,9818,7775,76919,6753,3383,1885,5474,9303,9653,7633,4803,1644,6524,4584,0764,2986,6346,4796,4286,609204191148143010,73113,53116,82116,7636,0006,0005,3004,70010,300
       Short-term Debt 
6,400
700
600
800
1,300
10,713
10,186
8,232
5,036
0
75
75
75
75
1,487
1,484
1,404
1,384
2,590
1,269
1,586
1,626
150
1,544
1,467
1,512
1,363
2,148
713
657
555
2,316
2,858
3,426
4,004
4,224
2,075
2,575
1,867
2,932
915
250
0
0
0
0
425
0
0
1,880
1,880
1,880
2,430
550
550
550
0
0
0
110
110
111
111
112
110
113
113
111
96
68
0
0
0
0
12,414
11,556
0
0
0
0
0
0
0
0
0000000011,55612,414000068961111131131101121111111101100005505505502,4301,8801,8801,8800042500002509152,9321,8672,5752,0754,2244,0043,4262,8582,3165556577132,1481,3631,5121,4671,5441501,6261,5861,2692,5901,3841,4041,4841,4877575757505,0368,23210,18610,7131,3008006007006,400
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
12,414
0
0
0
0
0
0
0
0
0
00000000012,41400000000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
3,500
3,100
3,400
4,100
3,500
3,891
3,746
3,931
3,933
0
38
38
75
83
622
619
625
464
603
668
613
628
385
353
557
633
903
1,053
627
594
789
1,007
1,053
972
1,203
1,186
1,355
1,541
1,520
1,602
252
106
417
302
338
240
425
1,120
1,015
757
1,684
558
1,039
409
512
419
176
129
199
480
489
502
1,251
655
1,355
1,412
546
953
750
678
947
813
846
807
97
971
932
534
662
680
726
1,082
1,511
1,861
1,8611,5111,082726680662534932971978078468139476787509535461,4121,3556551,2515024894801991291764195124091,0395581,6847571,0151,1204252403383024171062521,6021,5201,5411,3551,1861,2039721,0531,0077895946271,0539036335573533856286136686034646256196228375383803,9333,9313,7463,8913,5004,1003,4003,1003,500
       Other Current Liabilities 
400
900
1,300
1,100
1,200
2,159
2,889
1,368
1,761
0
30
36
41
46
4,493
4,325
4,450
4,786
1,105
2,139
2,259
2,399
2,629
1,583
1,739
1,819
2,664
2,345
1,848
2,086
18,331
2,446
4,866
5,583
15,645
16,515
5,337
5,455
5,491
6,161
2,964
2,621
1,921
1,791
2,230
1,794
524
1,088
742
1,044
874
49,162
25,990
17,732
1,629
454
512
817
605
603
443
605
359
520
317
1,162
1,776
1,049
1,255
2,003
1,980
2,143
1,669
1,463
-10,094
1,154
533
1,383
1,813
1,354
1,066
2,133
2,327
-1,861
-1,8612,3272,1331,0661,3541,8131,3835331,154-10,0941,4631,6692,1431,9802,0031,2551,0491,7761,1623175203596054436036058175124541,62917,73225,99049,1628741,0447421,0885241,7942,2301,7911,9212,6212,9646,1615,4915,4555,33716,51515,6455,5834,8662,44618,3312,0861,8482,3452,6641,8191,7391,5832,6292,3992,2592,1391,1054,7864,4504,3254,4934641363001,7611,3682,8892,1591,2001,1001,300900400
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,000
1,000
1,000
1,000
625
1,000
625
625
625
625
625
625
625
625
625
625
0
0
0
0
0
0
0
0
3,001
3,538
5,101
4,771
2,275
2,275
2,275
2,275
847
4,125
4,135
3,879
3,861
3,863
3,279
3,279
2,225
2,224
1,956
1,741
1,786
1,839
1,709
1,460
2,255
1,869
1,335
506
480
453
444
0
0
0
0
0
0
0
0
0
1,933
1,409
1,086
2,164
0
2,082
2,08202,1641,0861,4091,9330000000004444534805061,3351,8692,2551,4601,7091,8391,7861,7411,9562,2242,2253,2793,2793,8633,8613,8794,1354,1258472,2752,2752,2752,2754,7715,1013,5383,001000000006256256256256256256256256256251,0006251,0001,0001,0001,00000000000000000
> Total Stockholder Equity
5,700
5,500
6,000
5,600
8,300
2,771
3,779
3,240
-487
0
-143
-148
-191
-204
-906
-460
-758
-940
439
274
480
44
494
1,391
1,647
1,588
20
-723
8,746
5,052
-16,032
-2,137
-5,074
-6,031
-18,387
-19,711
-8,543
-6,289
6,459
12,215
45,297
42,799
38,166
35,254
31,812
19,069
-42
16,579
14,033
11,486
9,185
-19,119
1,168
6,357
21,230
29,720
27,300
20,908
15,612
12,955
16,178
13,519
20,134
17,902
32,877
28,724
24,814
53,647
50,167
38,132
34,911
30,618
26,669
24,052
20,218
16,279
14,230
9,574
7,377
5,336
49,977
45,637
39,202
34,634
34,63439,20245,63749,9775,3367,3779,57414,23016,27920,21824,05226,66930,61834,91138,13250,16753,64724,81428,72432,87717,90220,13413,51916,17812,95515,61220,90827,30029,72021,2306,3571,168-19,1199,18511,48614,03316,579-4219,06931,81235,25438,16642,79945,29712,2156,459-6,289-8,543-19,711-18,387-6,031-5,074-2,137-16,0325,0528,746-723201,5881,6471,39149444480274439-940-758-460-906-204-191-148-1430-4873,2403,7792,7718,3005,6006,0005,5005,700
   Common Stock
0
0
0
0
0
17
18
18
19
0
0
0
0
0
49
55
55
55
57
57
58
58
59
61
61
63
64
64
76
78
88
88
89
90
1
90
400
421
6
9
18
19
19
19
19
19
8
102
103
10
10
10
12
15
1
51
51
51
3
3
5
5
33
35
64
64
64
102
102
102
102
2
2
2
2
2
2
6
6
6
8
8
9
9
998866622222210210210210264646435335533515151115121010101031028191919191918964214009019089888878766464636161595858575755555549000001918181700000
   Retained Earnings -75,626-70,731-64,026-59,272-56,955-54,441-52,078-151,802-149,689-145,597-141,521-138,722-134,532-130,005-126,531-114,331-110,553-105,909-101,847-97,408-94,283-91,724-87,972-85,168-82,673-79,925-74,354-67,634-64,869-61,555-63,345-68,441-88,829-60,189-57,619-52,182-48,376-42,153-96,001-82,776-78,807-75,290-70,222-66,773-62,464-60,938-59,967-56,439-58,794-56,717-51,566-48,050-44,541-49,385-34,663-30,341-28,175-26,483-23,481-21,648-22,000-18,074-16,389-15,712-15,081-14,673-11,290-11,052-10,729-10,795-12,803-12,790-12,747-12,7420-18,385-13,094-11,337-9,850-4,300-2,700-1,900-1,800-1,500
   Capital Surplus 000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
7,200
7,300
7,900
8,300
12,600
12,604
15,098
16,316
17,879
0
12,599
12,599
12,599
12,599
9,840
10,214
10,239
10,445
15,055
15,298
16,134
16,376
18,509
23,330
22,920
24,691
26,439
27,387
39,012
39,637
33,265
42,316
42,887
45,445
38,329
38,992
47,496
53,257
67,390
74,670
112,052
113,003
113,437
114,042
114,569
115,051
42,103
64,852
66,111
69,094
69,364
69,700
69,597
69,687
82,784
94,488
94,833
95,211
95,533
95,624
101,341
101,486
111,825
112,150
130,221
130,508
130,660
164,099
164,396
164,560
164,915
165,193
165,476
165,658
165,848
165,969
166,030
61,647
61,812
62,285
109,260
109,532
109,869
110,230
110,230109,869109,532109,26062,28561,81261,647166,030165,969165,848165,658165,476165,193164,915164,560164,396164,099130,660130,508130,221112,150111,825101,486101,34195,62495,53395,21194,83394,48882,78469,68769,59769,70069,36469,09466,11164,85242,103115,051114,569114,042113,437113,003112,05274,67067,39053,25747,49638,99238,32945,44542,88742,31633,26539,63739,01227,38726,43924,69122,92023,33018,50916,37616,13415,29815,05510,44510,23910,2149,84012,59912,59912,59912,599017,87916,31615,09812,60412,6008,3007,9007,3007,200



5.4. Balance Sheets

Currency in USD. All numbers in thousands.




5.5. Cash Flows

Currency in USD. All numbers in thousands.




5.6. Income Statements

Currency in USD. All numbers in thousands.


5.7. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue9,738
Cost of Revenue-0
Gross Profit9,7389,738
 
Operating Income (+$)
Gross Profit9,738
Operating Expense-27,965
Operating Income-18,227-18,227
 
Operating Expense (+$)
Research Development18,798
Selling General Administrative9,167
Selling And Marketing Expenses0
Operating Expense27,96527,965
 
Net Interest Income (+$)
Interest Income1,937
Interest Expense-0
Other Finance Cost-0
Net Interest Income1,937
 
Pretax Income (+$)
Operating Income-18,227
Net Interest Income1,937
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-16,291-20,164
EBIT - interestExpense = -16,291
-16,291
-16,291
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-16,291-16,291
Earnings Before Interest and Taxes (EBITDA)-18,227
 
After tax Income (+$)
Income Before Tax-16,291
Tax Provision-0
Net Income From Continuing Ops-16,291-16,291
Net Income-16,291
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses27,965
Total Other Income/Expenses Net1,936-1,937
 

Technical Analysis of Cervomed
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Cervomed. The general trend of Cervomed is BEARISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Cervomed's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-28.6%) Bearish trend (28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Cervomed Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of CervoMed Inc..

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 7.79 < 8.1 < 11.79.

The bearish price targets are: 7.13 > 7.01 > 2.51.

Know someone who trades $CRVO? Share this with them.πŸ‘‡

CervoMed Inc. Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of CervoMed Inc.. The current mas is .

The long score for the Moving Averages is 5/14.
The longshort score for the Moving Averages is -4/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

CervoMed Inc. Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of CervoMed Inc.. The current macd is -0.36299553.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Cervomed price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Cervomed. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Cervomed price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
CervoMed Inc. Daily Moving Average Convergence/Divergence (MACD) ChartCervoMed Inc. Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of CervoMed Inc.. The current adx is 16.01.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Cervomed shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
CervoMed Inc. Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of CervoMed Inc.. The current sar is 10.33.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
CervoMed Inc. Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of CervoMed Inc.. The current rsi is 42.85. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
CervoMed Inc. Daily Relative Strength Index (RSI) ChartCervoMed Inc. Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of CervoMed Inc.. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Cervomed price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
CervoMed Inc. Daily Stochastic Oscillator ChartCervoMed Inc. Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of CervoMed Inc.. The current cci is -101.99295077.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
CervoMed Inc. Daily Commodity Channel Index (CCI) ChartCervoMed Inc. Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of CervoMed Inc.. The current cmo is -18.57871419.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
CervoMed Inc. Daily Chande Momentum Oscillator (CMO) ChartCervoMed Inc. Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of CervoMed Inc.. The current willr is -66.79006969.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Cervomed is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
CervoMed Inc. Daily Williams %R ChartCervoMed Inc. Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of CervoMed Inc..

CervoMed Inc. Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of CervoMed Inc.. The current atr is 0.7464712.

CervoMed Inc. Daily Average True Range (ATR) ChartCervoMed Inc. Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of CervoMed Inc.. The current obv is 137,406,420.

CervoMed Inc. Daily On-Balance Volume (OBV) ChartCervoMed Inc. Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of CervoMed Inc.. The current mfi is 22.61.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
CervoMed Inc. Daily Money Flow Index (MFI) ChartCervoMed Inc. Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for CervoMed Inc..

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-01-15STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-21RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2025-01-27STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-28STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-29WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-01-30SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-01-31STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-04STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-06STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-11WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-12STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-19STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-21STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-24CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-25SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-03STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-04CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-03-05STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-07CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-10SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-03-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-03-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-17STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-21STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-24RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-25ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-26SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-31MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-04-03RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-04-04MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-04-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-04-08CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-10STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-14CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-04-16STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-21STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-22CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-23STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-24STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-25STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-28CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-04-30STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-01STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-02STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-05-06CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-07WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-09CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-05-12STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-13STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-14CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-05-15STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-20STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-22STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-05-23MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-05-27DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-28STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-30STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-06-02STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-03STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-06-05STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

CervoMed Inc. Daily Candlestick Chart
DateCandlestick Pattern
2025-06-02Bullish Engulfing Candle Pattern

6.4. Technical Score

Let's check the technical score of CervoMed Inc. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5042.852
Ma 20Greater thanMa 508.212
Ma 50Greater thanMa 1008.999
Ma 100Greater thanMa 2006.358
OpenGreater thanClose7.630
Total2/5 (40.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Cervomed with someone you think should read this too:
  • Are you bullish or bearish on Cervomed? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Cervomed? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about CervoMed Inc.

I send you an email if I find something interesting about CervoMed Inc..


Comments

How you think about this?

Leave a comment

Stay informed about CervoMed Inc..

Receive notifications about CervoMed Inc. in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.